Last updated 9 months ago

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

300 patients around the world
Available in Spain, United States, Brazil, Argentina, Mexico
GlaxoSmithKline
300Patients around the world
This study is for people with
Rare diseases
Scleroderma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy